![Thomas Eastling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Eastling
Directeur/Membre du Conseil chez
GNI GROUP LTD.
Fortune : 88 650 $ au 31/05/2026
Profil
Thomas Wilson Eastling is currently Director at Shanghai Genomics, Inc. since 2015.
Mr. Eastling is Chief Financial Officer, Secretary & Director at Berkeley Advanced Biomaterials, Inc. since 2017.
Mr. Eastling is Director at GNI Group Ltd. since 2021.
Mr. Eastling is Non-Executive Director at Continent Pharmaceutical, Inc. since 2015.
Mr. Eastling is Director at GNI Hong Kong Ltd. since 2015.
Mr. Eastling is Chief Financial Officer & Director at Cullgen, Inc. since 2018.
Mr. Eastling is Director at Shanghai GEP Pharmaceuticals, Inc. since 2018.
Mr. Eastling is a Member of the National Association of Corporate Directors.
Mr. Eastling is Chief Financial Officer & Secretary at GNI USA, Inc. since 2015.
Mr. Eastling is Chief Financial Officer & Head-Investor Relations at Cullgen, Inc. (New).
Mr. Eastling is Chief Financial Officer at Gyre Therapeutics, Inc. starting 2023.
Former positions include Managing Director & Senior Vice President-Japan at Duff & Phelps Credit Rating Co. from 1999 to 2000.
Mr. Eastling was Managing Director at Fitch Group, Inc. Mr. Eastling was Director at Catalyst Biosciences, Inc. Mr. Eastling was Independent Director at Kai Wo Asset Management Ltd. Mr. Eastling was MD-Strategic Planning & Investor Relations at SoftBank Corp.
from 2001 to 2003.
Education includes a graduate degree from Thunderbird School of Global Management conferred in 1983 and an undergraduate degree from the University of Southern California conferred in 1981.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,02 % | 04/05/2026 | 15 000 ( 0,02 % ) | 88 650 $ | 31/05/2026 |
Postes actifs de Thomas Eastling
| Sociétés | Poste | Début |
|---|---|---|
| GNI GROUP LTD. | Directeur/Membre du Conseil | 01/03/2013 |
National Association of Corporate Directors
 National Association of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Operates non-profit organizations which provides essential resources that helps directors strength board leadership | Corporate Officer/Principal | - |
Shanghai GEP Pharmaceuticals, Inc.
 Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/06/2018 |
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Directeur Financier/CFO | 01/02/2018 |
Berkeley Advanced Biomaterials, Inc.
 Berkeley Advanced Biomaterials, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hydroxyapatite (HAP), tricalcium phosphate (TCP), and other calcium-based products | Directeur Financier/CFO | 01/07/2017 |
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Directeur/Membre du Conseil | 01/03/2015 |
Shanghai Genomics, Inc.
 Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Engages in therapeutic pharmaceutical products development and production | Directeur/Membre du Conseil | 01/03/2015 |
GNI Hong Kong Ltd.
 GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holdings company with interests in clinical trial research | Directeur/Membre du Conseil | 01/03/2015 |
GNI USA, Inc.
 GNI USA, Inc. BiotechnologyHealth Technology Engages in therapeutic pharmaceutical products development and production | Directeur Financier/CFO | - |
Anciens postes connus de Thomas Eastling
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░░░░ ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░ ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Thomas Eastling
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Duff & Phelps Credit Rating Co.
 Duff & Phelps Credit Rating Co. Investment ManagersFinance Issues credit ratings on corporate bonds, preferred stocks, commercial paper, CDs | Finance |
Thunderbird School of Global Management
 Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Genomics, Inc.
Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Engages in therapeutic pharmaceutical products development and production | Health Technology |
Berkeley Advanced Biomaterials, Inc.
Berkeley Advanced Biomaterials, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hydroxyapatite (HAP), tricalcium phosphate (TCP), and other calcium-based products | Health Technology |
SoftBank Corp.
 SoftBank Corp. Wireless TelecommunicationsCommunications Provides mobile communication, broadband and telecom services | Communications |
Fitch Group, Inc.
 Fitch Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides financial information services | Commercial Services |
National Association of Corporate Directors
National Association of Corporate Directors Miscellaneous Commercial ServicesCommercial Services Operates non-profit organizations which provides essential resources that helps directors strength board leadership | Commercial Services |
GNI Group Ltd.
 GNI Group Ltd. BiotechnologyHealth Technology Engages in research and development, manufacture and sale of pharmaceutical products | Health Technology |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and sells pharmaceutical products | Health Technology |
GNI Hong Kong Ltd.
GNI Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holdings company with interests in clinical trial research | Commercial Services |
GNI USA, Inc.
GNI USA, Inc. BiotechnologyHealth Technology Engages in therapeutic pharmaceutical products development and production | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Kai Wo Asset Management Ltd.
 Kai Wo Asset Management Ltd. Investment ManagersFinance Kai Wo Asset Management invests in small and middle market companies located in Asia pacific region. the firm focuses in building materials, food & beverage and whisky & spirits. It provides financing for buyout transactions. | Finance |
Cullgen, Inc.
Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Health Technology |
Shanghai GEP Pharmaceuticals, Inc.
Shanghai GEP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
